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Abstract
When it comes to tumors of the head and neck, there is currently no reliable method for
finding all the metastases of the neck. Therefore, we follow the rule of performing an
elective dissection in the patients where more than 20% of metastases are expected. Even
then, there are some patients with local recurrences. The explanation most likely lies in the
incorrect histopathological diagnosis and unrecognized metastases. The ability to recog-
nize smaller metastases can be accomplished by the use of the concept of the sentinel
lymph node. This chapter describes the assessment of the neck status in 40 patients. In 18
patients, we have found metastases in the sentinel lymph nodes. It is important to note
that in eight patients, metastases were found only after the use of serial cuts and
immunohistological staining.
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1. Introduction
Metastases of the regional lymph nodes of the neck are the most important independent
prognostic factor in the cancer of upper airways and upper digestive tract [1]. In the tumors
of the same size, the presence of metastases of even one lymph node reduces the 5-year
survival rate by 50% [2]. Despite the novel diagnostic methods, an accurate diagnosis of
clinically nonsuspicious lymph nodes remains a big problem. There is currently no available
method with which we could accurately find all the metastases of the regional lymph nodes.
There are still a number of unsolved questions in regards to patients with a clinically negative
neck. Thus, there is a dilemma of which investigative method gives us the most accurate
results, do we need to treat a clinically negative neck, what is the optimal treatment, do we
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
need to treat the contralateral side of the neck, what are the chances of successful treatment of
regional recurrences, and can we adjust the treatment to the etiology of the tumor [3].
Clinical examination with palpation is absolutely not sufficient for discovering small and
occult metastases [4]. Newer methods such as ultrasound (US), computed tomography (CT),
and magnetic resonance imaging (MRI) allow for a discovery of more occult metastases, but
their use also results in a large number of false positive metastases [5]. With the use of CT and
MRI, there is also a limitation of discovering the metastases of lymph nodes smaller than 5 mm
[3]. The best results are achieved with the ultrasound investigation of the neck combined with
a cytologic punction [6]. Currently, no method is able to identify all of the occult metastases [7].
Therefore, we perform an elective dissection in the patients where more than 20% of occult
metastases are expected [8–10]. Despite this, there remain a certain percentage of patients in
whom the regional recurrences of the operated neck occur [11, 12]. Why is that? How can we
overcome this? The most likely explanation is the unrecognized metastases in the dissected
lymph nodes of the neck, overlooked by the classical histopathological examination. This
oversight leads to inadequate treatment (no adjuvant radiotherapy) in these patients. An
accurate neck status can be acquired by the use of the concept of the sentinel lymph node.
There is a large increase of patients with changed classification even with the use of only a
classical histopathological examination. According to the literature, the classification increases
in 49% and decreases in 21% [13]. With the use of classical histopathological examination, the
pathologist examines the removed lymph nodes with one or two cuts along the longitudinal
axis, which can lead to the oversight of the smaller metastases. With the use of the concept of
sentinel lymph node, the lymph nodes are examined with serial cuts and immunochemical
staining. This means that we can discover all of the metastases and can accurately determine
the classification of the neck, which leads to the discovery of additional patients needing the
adjuvant therapy. If elective dissection and checking for metastases of the lymph nodes are not
performed, and we delay the adjuvant treatment until the possible appearance of metastases of
the regional lymph nodes, the prognosis is worse [14].
2. The concept of the sentinel lymph node
The sentinel lymph node is the one which drains the lymph from the tumor first [15]. We
assume that the tumor thrombus stops in the first lymph node that it reaches, and if there are
no metastases in this lymph node, there will also be none in the other lymph nodes.
This concept is widely accepted in the surgical treatment of the malignant melanoma of the
skin, as well as in the surgical treatment of breast cancer [16, 17]. In the treatment of the
malignancies of the head and neck, there is a problem, which was highlighted by O’Brien
[18], in the use of the concept of the sentinel lymph node due to the proximity of the tumor and
the sentinel lymph node, rapid spread of the radiocolloid in the lymphatic pathways, a large
number of the lymph nodes accumulating the radiocolloid, and often small, hard to reach
lymph nodes.
Cancer Survivorship86
Even though these difficulties referred to the skin melanomas, we encounter the same prob-
lems in the surgical treatment of squamous cell carcinoma of the upper airways and upper
digestive tract. This is one of the main reasons why the use of the concept of the sentinel lymph
node in the head and neck tumors is not widespread. The other important reason is that we do
not have a fast and accurate method with which we could intraoperatively discover all of the
metastases of the sentinel lymph nodes [19, 20]. A big problem arises if a pathologist discovers
after the surgery the metastases in the lymph nodes that were not discovered with a frozen
section procedure. In these cases, a reoperation is required, usually done 3–4 weeks after the
initial surgery. Although we know that this can happen, it is still a very unpleasant experience
for both the patient and the surgeon.
The examination of the sentinel lymph node with serial cuts and immunohistochemical
staining allows for the discovery of even the smallest metastases [21]. It is important that if no
metastases are found in the sentinel lymph node, there were also none in the other lymph
nodes [22].
3. Selective dissection of the neck with the identification of the sentinel
lymph node
In the cases where more than 20% of occult metastases are expected, we decide for the selective
dissection, which means the removal of the lymphatics of the regions in which the metastases
are expected [8–10]. In the oral cavity cancer and the oral pharynx, this depends on the
localization of the tumor. In the tumors that are close to the midline, we must make a decision
about the unilateral or bilateral removal of the lymph nodes. The decision can be made easier
with the use of scintigraphy which can show us where the lymph from the region of the tumor
drains. We remove the region of the neck which contains the sentinel lymph and additionally
two adjoining regions. If the lymph is draining to both sides of the neck, we perform a bilateral
selective dissection.
It has been proven that the survival of the patients in whom the elective dissection has been
done is increased compared to the patients where the dissection was only done after the
appearance of the metastases [14].
The patient disfiguring after an elective selective dissection is relatively minor when
performed by an experienced surgeon. However, there is always a certain esthetic deformation
larger than the one where only a sentinel lymph node is removed. There is also always a risk of
damaging the marginal, accessory, lingual, and hypoglossal nerves. This nerve damage is rare
in a careful surgical dissection.
After the removal of the lymphatics of the determined regions, we identify and remove the
sentinel lymph node from the dissected material. The node is then examined by the pathologist
with the serial slices at 100–150 microns and immunohistochemical staining. The remaining
lymph nodes are examined with the classical histopathological methods with one or two slices
along the longitudinal axis and staining with hematoxylin and eosin.
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4. Preoperative identification of the sentinel lymph node
Preoperatively we determined the neck status of all the patients with the ultrasound. The
study included the patients with T1 and T2 cancers of the oral cavity and oropharynx in whom
no suspicious lymph nodes were found by ultrasound.
Approximately, an hour before the surgical procedure, a lymphoscintigraphy of the tumor
region was performed. The static and dynamic scintigraphy allowed for the localization of the
sentinel lymph node, which was marked on the skin.
5. Scintigraphy
For the determination of the sentinel lymph node, we used the Tc-nanocolloid. We used
Nanocoll, produced by Amersham Health (Italy). Nanocoll is a set for the preparation of 99 m
Tc-albumin nanocolloid. At least 95% of the parts of this colloid are equal or smaller than 80 nm.
We used 2–4 mCi, which correlates to 7,4–14,8 mBq. The amount of the radiocolloid used
depended on the size of the tumor. Radiocolloid was injected at four different areas in close
proximity to the tumor (above, below, left, and right; or clockwise—12, 3, 6, and 9 o’clock). By
changing the needle positioning, we are able to infiltrate by colloid the entire tumor region.
After the injection of the radiocolloid, the patient rinsed their mouth with water to remove any
possible radiocolloid residues which might have influenced the investigation. 10 minutes after
the application of the radiocolloid, we started to follow its movement along the lymphatics
into the closest lymph nodes. For the detection of the radiocolloid, we used a gamma-ray
camera Picker SX 300. Dynamic scintigraphy lasted between 45 and 60 min.
After an hour, we also made static recordings in the anteroposterior and lateral projections.
Static scintigraphy allowed for the marking of the sentinel lymph node location on the overly-
ing skin of the neck. If we were unable to identify the sentinel lymph node after an hour, we
repeated the static recordings again in 30 min.
In this way, with the use of static and dynamic scintigraphy, we were able to identify the
correct sentinel lymph nodes and limit any possible “skip”metastases [23].
6. Intraoperative identification of the sentinel lymph node
After we localized the sentinel lymph nodes with scintigraphy, we performed an elective
selective dissection. After raising the subplatysmal skin flap, we injected the methylene blue
dye to the same area where scintigraphy was performed before.
For the methylene blue dye, we used a Patent Blue V dye (Laboratorie Guerbet, Aulanay-Sous-
Bois, France). The amount injected depended on the size of the tumor (from 0.5 to 2 ml) since
the entire area of the tumor had to be filled. We observed the spreading of the dye and
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identified the sentinel lymph node as the one which colored blue. With the use of gamma-ray
detector, we confirmed the accumulation of the radioisotope in the lymph node.
If the accumulation was 3-times larger than that of its surroundings, we considered it as a warm
node, and therefore as our sentinel lymph node. Most of the sentinel lymph nodes turned blue
and accumulated the radioisotope. However, there were some lymph nodes which only turned
blue or only accumulated the radiocolloid, but not both. We treated these as the sentinel ones as
well. We removed all the nodes that were assumed as the sentinel ones from the dissected
material and sent them separately to a histopathological examination with the serial slicing. The
rest of the lymph nodes were examined with the classic histopathological methods.
7. Examination of the sentinel lymph node and dissected material of the
neck
The sentinel lymph node was prepared by the pathologist in paraffin blocks with serial cuts at
100–150 microns. With serial cuts, the alternating staining with hematoxylin and eosin and
immunocytochemical staining with cytokeratin were used.
As a reagent for immunohistochemical staining, a reagent produced by Dako-Glostrup (mono-
clonal mouse anti-human cytokeratin clone AE 1/AE 3) was used.
All the remaining removed lymph nodes were examined with the classical methods of staining
with hematoxylin and eosin in paraffin blocks with 1–3 slices along the longitudinal axis of the
lymph node.
8. Results
Forty patients were treated with this method. In 18 out of 40 patients, we found metastases. In
10 of these 18 patients, the metastases were already discovered with the classical method (i.e.,
first cut of the sentinel lymph node). In 8 of the 18 patients with metastases, the metastases
were only discovered after the serial slicing and immunocytochemical staining. In 3 of 10
patients in whom the metastases were already found with the classical method, the metastases
were also found in the other lymph nodes, which meant that the N classification in these three
patients changed from N0 to N2b. With the use of serial cuts of all sentinel lymph nodes, the
classification changed from N0 to N2b in 4 of 7 patients.
9. Discussion
A final and accurate status of the neck provides us with a very good evaluation of the actual
state of the neck and the need for eventual inclusion of the additional adjuvant radiotherapy.
With the use of classical histopathological examination of removed lymph nodes after elective
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dissection, we would have missed 8 out of 40 patients who did have metastases. Even with the
use of only histopathological examination of the removed lymph nodes, we discovered 10
patients with metastases of the regional lymph nodes. With the use of classical method, the
occult metastases were therefore discovered in 25% of the patients. This is an expected propor-
tion of patients with the occult metastases [24–26]. To these patients, we have to add the patients
in whom we have found the metastases with the serial cuts of the sentinel lymph nodes. There
were eight of these patients. We see that the number of patients with occult metastases was close
to 50%. With the use of classical histopathological examination, we would have discovered only
around a half of the patients with the occult metastases. We cannot afford to examine all of the
removed lymph nodes by serial cuts and immunohistochemical staining, due to the lack of
personnel and funding. In selective dissection of the neck, we remove on average 13–15 lymph
nodes, which would amount to more than 200 slices needing pathologist examination. Still, the
question whether we would discover more patients with occult metastases remains. If we accept
the concept of the sentinel lymph node [27, 28] that if there are no metastases in the sentinel
lymph node that there are also no metastases in the other lymph nodes, the only question
remains if the correct sentinel lymph node was selected. With the use of radiocolloid and
concurrent intraoperative use of methylene blue, the identification is very reliable [29]. Even
with the surgical method, when we remove only the sentinel lymph nodes, we discover many
occult metastases with serial slices [30] that we otherwise would not have. This method has some
weaknesses, mainly the possibility of missed metastases intraoperatively which are discovered
afterwards [31] leading to an additional surgical procedure. Another potential problem is that we
do not remove the true sentinel lymph node, which can happen due to a limited access and
consequent inability to visualize the lymph flow by methylene blue. We may only see if the
lymph node has stained or not, but wemay not see if any other lymph node before has stained as
well. In selective dissection where to gain access, we raise the entire subplatysmal skin flap, and
we have a good visualization of the lymph drainage from the area surrounding the tumor. The
visualization is also good when we use the gamma-ray detector to identify the lymph nodes
which we marked on the skin when performing the scintigraphy. We often see many smaller
lymph nodes on a very narrow area and if we would rely on the gamma-ray detector only, we
could easily misidentify the sentinel lymph node. We can observe that after the removal of the
sentinel lymph node, only the patients with regional recurrent disease have a very poor progno-
sis [32]. The possibility for recurrence is greatly increased if we have a larger number of meta-
static sentinel lymph nodes. Micrometastases and isolated tumor cells do not have a larger
influence on the possible recurrence [32]. The reason for this could be an overlooked true sentinel
lymph node and the possible changes of lymph drainage and metastases found at unpredictable
locations later on. With selective dissection where we remove the lymph nodes from the region
of the sentinel lymph node’s location and two adjoining regions, there is basically no chance to
not remove all the lymph nodes with metastases, especially if adequate ultrasound or CT
diagnostics were performed preoperatively.
Another question is if all of the metastases of the removed lymph nodes are found. If with
serial slices and immunohistochemical staining in the sentinel lymph node we discover the
metastases, there is also a possibility that the metastases are present in other lymph nodes. In 7
out of 18 patients, these metastases were discovered, even with the classical examination only.
Therefore, there is a small chance that we have not discovered all of the micrometastases and
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isolated tumor cells in the lymph nodes. If we assume that all of the lymph nodes containing
these have been removed, we can conclude that they are not necessary for the further disease
course. Micrometastases supposedly do not have an influence on the possibility of regional
recurrences [32].
10. Conclusion
We can see that we do not have a method to preoperatively prove smaller metastases of the
lymph nodes of the patients with the cancer of the upper airways and upper digestive tract.
Even after a selective dissection with classical histopathological methods of removed lymph
nodes, around 10% of the patients with metastases are missed. With a somewhat modified use
of the concept of the sentinel lymph node, we can significantly decrease this number by
discovering basically all of the metastases of the regional lymph nodes. A prospective study is
needed to prove if the smaller metastases have an influence on the patient’s survival and if
they should be treated with additional adjuvant radiotherapy. However, there is an ethical
question of not providing additional therapy to the patients with smaller metastases in numer-
ous lymph nodes, despite the fact that they would not be receiving it with the classical
examination of the removed lymph nodes anyway. There are also regional recurrences in the
patients who have had a selective dissection, and the pathologist did not find the metastases in
the removed lymph nodes. The percentage of these recurrences indicates that this might be
these unrecognized metastases.
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